|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
2,080,000 |
Market
Cap: |
1.49(M) |
Last
Volume: |
1,523,296 |
Avg
Vol: |
1,519,138 |
52
Week Range: |
$0.714 - $0.714 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Sonoma Pharmaceuticals is a global healthcare provider for developing and producing stabilized hypochlorous acid products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. Co.'s products include: Celacyn® Scar Management Gel, which provides scar management by protecting and moisturizing wound and scar sites; Microcyn® Wound Care Management, which provides improved healing properties; Acuicyn Eyelid and Eyelash Hygiene, which provides eyelid and eyelash hygiene; and Microdacyn60® Oral Care, which supports the treatment of mouth and throat infections and the debridement and moistening of mouth lesions and thrush.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Alimi Hojabr |
Chief Executive Officer |
|
2012-12-10 |
4 |
B |
$0.64 |
$3,507 |
D/D |
5,500 |
1,031,050 |
2.73 |
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2012-12-07 |
4 |
B |
$0.65 |
$3,438 |
D/D |
5,300 |
1,031,050 |
2.73 |
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2012-12-06 |
4 |
B |
$0.63 |
$5,703 |
D/D |
9,000 |
1,020,250 |
2.81 |
- |
|
Schutz James J |
Chief Operating Officer |
|
2012-11-09 |
4 |
B |
$0.78 |
$10,380 |
D/D |
13,000 |
66,500 |
2.81 |
- |
|
Schutz James J |
Chief Operating Officer |
|
2010-08-09 |
4 |
B |
$1.85 |
$34,926 |
D/D |
18,500 |
53,500 |
2.81 |
- |
|
French Gregory M |
Chief Operating Officer |
|
2010-06-10 |
4 |
B |
$1.99 |
$6,013 |
D/D |
3,020 |
52,760 |
2.81 |
- |
|
French Gregory M |
Chief Operating Officer |
|
2010-06-07 |
4 |
B |
$2.02 |
$6,223 |
D/D |
3,076 |
49,740 |
2.81 |
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2010-03-10 |
4 |
S |
$3.16 |
$47,343 |
D/D |
(15,000) |
1,011,250 |
|
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2010-03-09 |
4 |
OE |
$1.10 |
$16,500 |
D/D |
15,000 |
1,026,250 |
|
- |
|
Conley Richard K |
Director |
|
2010-03-09 |
4 |
OE |
$0.85 |
$12,750 |
D/D |
15,000 |
122,650 |
|
- |
|
Schutz James J |
Chief Operating Officer |
|
2009-12-09 |
4 |
B |
$1.76 |
$35,820 |
D/D |
20,000 |
35,000 |
2.81 |
- |
|
Miller Robert E |
Chief Financial Officer |
|
2009-11-11 |
4 |
B |
$1.65 |
$6,600 |
D/D |
4,000 |
73,000 |
2.74 |
- |
|
Miller Robert E |
Chief Financial Officer |
|
2009-11-10 |
4 |
B |
$1.67 |
$15,239 |
D/D |
9,000 |
69,000 |
2.74 |
- |
|
Conley Richard K |
Director |
|
2009-09-10 |
4 |
S |
$2.75 |
$69,129 |
D/D |
(25,000) |
107,650 |
|
- |
|
Conley Richard K |
Director |
|
2009-09-03 |
4 |
A |
$0.85 |
$76,500 |
D/D |
90,000 |
132,650 |
|
- |
|
Schutz James J |
Vice President |
|
2009-08-12 |
4 |
B |
$2.00 |
$10,199 |
D/D |
5,000 |
15,000 |
2.81 |
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2009-08-10 |
4 |
S |
$1.97 |
$658,277 |
D/D |
(315,000) |
1,011,250 |
|
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2009-08-10 |
4 |
OE |
$0.15 |
$48,300 |
D/D |
315,000 |
1,326,250 |
|
- |
|
Burlingame Robert |
Director |
|
2009-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
435,897 |
1,294,931 |
|
- |
|
Burlingame Robert |
Director |
|
2009-06-01 |
4 |
B |
$1.17 |
$666,667 |
D/D |
569,801 |
859,034 |
2.39 |
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2009-03-06 |
4 |
S |
$1.05 |
$13,853 |
D/D |
(13,200) |
1,011,250 |
|
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2009-03-05 |
4 |
S |
$1.14 |
$8,923 |
D/D |
(7,800) |
1,024,450 |
|
- |
|
Burlingame Robert |
Director |
|
2009-03-04 |
4 |
B |
$1.17 |
$255,334 |
D/D |
218,234 |
289,233 |
2.39 |
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2009-03-04 |
4 |
S |
$1.16 |
$20,568 |
D/D |
(17,800) |
1,032,250 |
|
- |
|
Alimi Hojabr |
Chief Executive Officer |
|
2009-03-03 |
4 |
S |
$1.23 |
$7,648 |
D/D |
(6,200) |
1,050,050 |
|
- |
|
115 Records found
|
|
Page 4 of 5 |
|
|